Bladder cancer specialists

Jordan E. Angell, M.D.
Curriculum Vitae

Jordan E. Angell, M.D.

American Board of Urology

  • Colgate University, B.A.
  • George Washington University School of Medicine, M.D.
  • Emory University School of Medicine, General Surgery Internship
  • Emory University School of Medicine, Urology Residency
  • Ohio State University, Department of Urology, Fellowship, Robotic Urologic Surgery

blue speech bubble


 


What Patients Are Saying About Dr. Angell


 




 


Dr. Angell practices general urology and specializes in minimally invasive techniques to treat urological conditions. His expertise includes robotic, laparoscopic, and endoscopic management of prostate, bladder and kidney cancer, as well as minimally invasive treatments for ureteral disease, benign prostatic hyperplasia (BPH/enlarged prostate), kidney stones and the medical and surgical management of erectile dysfunction including penile prosthesis.


He was elected to the prestigious Alpha Omega Alpha National Honor Medical Society in 2006, and he received the Tauber Scholarship from George Washington University for two consecutive years. While in medical school, Dr. Angell was elected to the Gold Humanism Honor Society, which is comprised of individuals who have been recognized for practicing patient-centered medical care by modeling the qualities of integrity, excellence, compassion, altruism, respect and empathy. During his last year of residency at Emory University School of Medicine, Dr. Angell was the urology chief resident. His honors also include the William Hollis Cooner Outstanding Urology Resident Award and the Outstanding Urologic Laparoendoscopic Resident Award, both from Emory University.


Dr. Angell has published and presented numerous papers on a range of urologic subjects including robotics, endourology, laparoscopic approaches for distal ureteral strictures, renal pelvic tumors and prostate and kidney cancer.


Dr. Angell grew up in Baltimore and graduated from Gilman School. He is a member of the American Urological Association, the Endourological Society, the Society of Laparoendoscopic Surgeons and the Alpha Omega Alpha National Honor Medical Society. He was also elected to The Gilman School's Alumni Association Board of Governors.


 


Rian J. Dickstein, M.D., F.A.C.S.
Curriculum Vitae

Rian J. Dickstein, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • The University of Texas MD Anderson Cancer Center, Urologic Oncology Fellowship
  • Boston Medical Center (Boston University), Urology Residency
  • Boston Medical Center (Boston University), General Surgery Internship
  • Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, M.D.
  • Rutgers University, B.A.


  • Cancer Liaison Physician for the Tate Cancer Center at The University of Maryland Baltimore Washington Medical Center​ 




  • Clinical Assistant Professor - Department of Surgery at University of Maryland School of Medicine 




Dr. Dickstein is a urologic oncologist who trained at the world-renowned MD Anderson Cancer Center in Houston, Texas.  Dr. Dickstein focuses on all urologic cancers and specializes in open, laparoscopic and robotic surgeries. His expertise includes the treatment of bladder cancer (non-invasive and locally advanced), kidney cancer (small or locally advanced tumors), and prostate cancer (including primary and salvage surgery for complex cases).


Dr. Dickstein also specializes in the treatment of testicular and penile cancers. He has published numerous articles on urologic cancers in multiple medical journals and has presented at national meetings on subjects primarily related to bladder and penile cancers.


He is a member of the Bladder Cancer Advocacy Network (BCAN) Scientific Advisory Board, which is composed of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in the U.S and Canada.


Dr. Dickstein received a Merit Award for the 2011 Genitourinary Cancers Symposium by the American Society of Clinical Oncology, was a first place winner of the Max K. Willscher Resident Research Award competition at the New England Section of the American Urologic Association, and he was presented with the Editor's Award of Excellence for an Original Study from the Uro Today International Journal.


Dr. Dickstein was inducted into the Alpha Omega Alpha Honor Medical Society while he was in medical school.


 


William T. Dowling, M.D., F.A.C.S.
Curriculum Vitae

William T. Dowling, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Chief of Urology, Franklin Square Hospital
  • University of Virginia, B.S.
  • Medical College of Virginia, M.D.
  • Medical College of Virginia General Surgery and Urology Residency

  • Chief of Urology, MedStar Franklin Square Medical Center


 


As a general urologist, Dr. Dowling has particular interest in the treatment of enlarged prostate (BPH), the surgical management of kidney stone disease and in the laparoscopic treatment of renal and ureteral tumors and urologic oncology.


Dr. Dowling's clinical practice is based at Franklin Square Hospital Center, where he is the Section Chief of Urologic Surgery. He also serves on the Executive Committee of Chesapeake Urology.


Dr. Dowling has been selected as a "Top Doctor" by his peers in Baltimore magazine in the Urologists category several times. He has also been selected as a "Super Doctor" by his peers in The Washington Post magazine. 


Peter S. Filderman, M.D., F.A.C.S.
Curriculum Vitae

Peter S. Filderman, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Chief of Urology, St. Agnes Hospital
  • Medical Director, Maryland Kidney Stone Center
  • University of Pennsylvania, B.A., Cum Laude
  • University of Connecticut School of Medicine, M.D.
  • University of Maryland Medical Center Urology Residency

  • Chief of Urology, Saint Agnes Hospital


 


Dr. Filderman's main areas of interest are kidney stone disease and male prostatic disease, urologic cancers, and vasectomies. He has performed many minimally invasive procedures to treat prostatic enlargement and continues to offer all available outpatient procedures used to treat urologic disease in the ambulatory surgery setting.


David S. Goldstein, M.D., F.A.C.S.
Curriculum Vitae

David S. Goldstein, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Boston University, B.S.
  • Mount Sinai School of Medicine, M.D.
  • Harvard Medical School Urology Residency Program

Dr. Goldstein has been involved in several research studies involving pharmacological and medical device testing. His clinical areas of interest are minimally invasive surgery for prostate, kidney and bladder cancers, including robotic and laparoscopic surgery; the treatment of kidney stones; and female and male incontinence.


Steven R. Jaskulsky, M.D., F.A.C.S.
Curriculum Vitae

Steven R. Jaskulsky, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Western Maryland College, B.A.
  • University of Maryland School of Medicine, M.D.
  • University of Maryland Urology Residency Program

Dr. Jaskulsky has been in the private practice of urology since 1986. He has particular interests in the fields of urologic oncology, endourology (stone disease), pediatric urology, prostate diseases and sexual dysfunction.  Dr. Jaskulsky was named as one of the U.S. News Top Doctors for 2012.


Sankar J. Kausik, M.D., F.A.C.S.
Curriculum Vitae

Sankar J. Kausik, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Chief of Urology, Upper Chesapeake Medical Center
  • Chief of Urology, Harford Memorial Hospital
  • Rensselear Polytechnic Institute, B.S., Summa Cum Laude
  • Albany Medical College, M.D., Summa Cum Laude
  • Mayo Clinic Urology Residency and Fellowship Program
  • Mayo Medical School (2001)

  • Assistant Medical Director, Summit Ambulatory Surgical Center

  • Director, BPH Program, Chesapeake Urology Associates

  • Chief of Urology, Upper Chesapeake Medical Center

  • Chief of Urology, Harford Memorial Hospital 


Dr. Kausik's specific clinical interests include urologic oncology, with a focus on prostate cancer surgery, benign prostate conditions and minimally invasive treatment for BPH, kidney stone disease (surgical and medical management), sexual dysfunction and incontinence.


He has published and presented numerous papers at regional and national urology conferences. He remains active in clinical research with Chesapeake Urology Research Associates. 


Nicholas T. Leone, M.D.
Curriculum Vitae

Nicholas T. Leone, M.D.

American Board of Urology

  • University of Delaware
  • Jefferson Medical College at Thomas Jefferson University
  • Hospital of the University of Pennsylvania, general surgical internship
  • Hospital of the University of Pennsylvania, urologic residency
  • Thomas Jefferson University Hospital, fellowship in endourology, laparoscopy, and robotic surgery

Dr. Leone practices general urology with a focus on advanced endoscopic and minimally-invasive techniques for the treatment of both benign and malignant urologic diseases. He specializes in the ureteroscopic treatment of kidney stones, ureteral obstruction, and ureteral cancer, as well as laparoscopic and robotic surgery for ureteropelvic junction obstruction and cancer of the prostate, bladder and kidneys.


He graduated magna cum laude from Jefferson Medical College and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his urologic residency at the Hospital of the University of Pennsylvania, receiving numerous awards and honors including the Outstanding Educational Efforts in Urology Award and the Society of Laparoendoscopic Surgeons Resident Achievement Award. He most recently completed the prestigious C.R. Bard Fellowship in Endourology, Laparoscopy, and Robotic Surgery at Thomas Jefferson University.


Brian M. Levin, M.D., F.A.C.S.
Curriculum Vitae

Brian M. Levin, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • University of Maryland, B.S., Cum Laude
  • University of Maryland, M.D., Summa Cum Laude
  • University of Pennsylvania - Urology Residency
  • Vanderbilt University Fellowship in Laparoscopic Surgery, Endourology and Robotics

blue speech bubble


What Our Patients Are Saying About Dr. Levin...


 








 

 


Dr. Levin's special interests include laparoscopic renal and adrenal surgery for malignant and benign disease processes, endoscopic surgery and robotic prostatectomy.


His honors include the Howard Pollack Award and the nationally recognized Pfizer Scholar in Urology Award. He was an investigator in renal tissue effects of radiofrequency ablation in both animal and human models. 


Benjamin H. Lowentritt, M.D., F.A.C.S.
Curriculum Vitae

Benjamin H. Lowentritt, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Director, Minimally Invasive Surgery and Robotics, Chesapeake Urology Associates
  • Harvard College, A.B., History of Science, Magna Cum Laude
  • Baylor College of Medicine, M.D.
  • University of Maryland Medical System General Surgery Residency
  • University of Maryland Medical System Urology Residency
  • Tulane University Medical Center Fellowship in robotic, laparoscopic, and advanced endoscopic urology

  • Director, Minimally Invasive Surgery and Robotics, Chesapeake Urology Associates

  • Director, Prostate Cancer Care Program, Chesapeake Urology Associates

  • Past President, Baltimore City Medical Society



Dr. Lowentritt has a general urology practice with a focus on minimally invasive techniques to treat urological conditions. His expertise includes robotic, laparoscopic, and endoscopic management of renal, bladder, and prostate cancer, as well as minimally invasive options for benign prostatic hyperplasia (BPH), kidney stones, pelvic organ prolapse, and ureteropelvic junction obstruction. 


Dr. Lowentritt has been at the forefront of robotic urology procedures and was the first surgeon in Maryland to perform robot assisted surgery for bladder cancer. 


He has authored numerous articles and chapters on subjects including robotic surgery, erectile dysfunction, pediatric urology, female urology and the urological management of patients after renal transplantation.


Dr. Lowentritt has been selected as a "Super Doctor" by his peers in The Washington Post magazine and as a "Top Doctor" in Baltimore magazine. Dr. Lowentritt serves on the Board of Directors for the Baltimore City Medical Society.


 


Geoffrey N. Sklar, M.D., F.A.C.S.
Curriculum Vitae

Geoffrey N. Sklar, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Chief of Urology, Baltimore Washington Medical Center
  • Chief of Genitourinary Oncology, Baltimore Washington Medical Center
  • Chief Medical Officer, Chesapeake Urology Associates
  • University of Maryland College Park, B.S.
  • University of Maryland School of Medicine, M.D.
  • University of Maryland Medical System Surgical Residency Program
  • University of Maryland Medical System Urology Residency Program
  • University of Maryland Medical Center, Former Chief of Urology, Former Residency Director

  • Chief Medical Officer, Chesapeake Urology Associates

  • Chief of Urology, University of Maryland Baltimore Washington Medical Center

  • Chief of Genitourinary Oncology, University of Maryland Baltimore Washington Medical Center


  • Assistant Chief of Surgery, University of Maryland Baltimore Washington Medical Center




  •  


    President, Medical Staff, University of Maryland Baltimore Washington Medical Center 




Dr. Sklar practices general urology and focuses on kidney cancer, bladder cancer, erectile dysfunction, and Peyronie's disease. Dr. Sklar is a local leader in bladder cancer treatment as well as continent urinary diversion and neobladder, and performs blue light cystoscopy, a new technology for detecting and diagnosing bladder tumors. 


Dr. Sklar is a leading physician in Maryland and has been recognized as a Top Doctor by Baltimore magazine in 2011 and 2012 and by Annapolis magazine as a Top Doctor in 2010 and 2012. He has also been selected as a "Super Doctor" by his peers in the Washington Post magazine. 


Named an Innovator in Urology, Dr. Sklar has participated in numerous clinical trials. He serves on the editorial board of the International Journal of Impotence Research and also serves as a reviewer for the Journal of Urology, World Journal of Urology, Urology, and the Asian Journal of Andrology.


Ronald F. Tutrone, Jr., M.D., F.A.C.S., C.P.I.
Curriculum Vitae

Ronald F. Tutrone, Jr., M.D., F.A.C.S., C.P.I.

American Board of Urology;
Fellow of the American College of Surgeons


  • Chief, Division of Urology, Greater Baltimore Medical Center

  • Medical Director, Chesapeake Urology Research Associates


 


Dr. Tutrone's clinical interests include treatment of urologic malignancies including kidney, bladder and prostate; laparoscopic treatment of renal and adrenal tumors; kidney stone treatment; urinary incontinence in men and women; and prostate disorders.


He has been voted a "Top Doctor" by Baltimore magazine six times, and a "Super Doctor" for Urology in the Washington Post Magazine Washington, DC, Northern Virginia and Baltimore.


Dr. Tutrone has authored numerous articles in the urology literature. He has been principal investigator in more than 200 clinical research trials. He Chairman of the William E. Kalhert Endowment for Urological Research and Medical Director, of Chesapeake Urology Research Associates.


P. Sean Van Zijl, M.D.
Curriculum Vitae

P. Sean Van Zijl, M.D.

American Board of Urology

  • Northwestern University, B.A.
  • Temple University School of Medicine, M.D.
  • University of Maryland Medical System General Surgery Residency Program
  • University of Maryland Medical System Urology Residency Program

Dr. Van Zijl practices general urology with special interests in stone disease, urologic oncology, and benign prostatic hyperplasia (BPH). During his residency, Dr. Van Zijl conducted research in interstitial cystitis in the laboratory of Dr. Toby Chai.